• LAST PRICE
    4.8955
  • TODAY'S CHANGE (%)
    Trending Down-0.7445 (-13.2004%)
  • Bid / Lots
    4.8900/ 4
  • Ask / Lots
    4.9000/ 4
  • Open / Previous Close
    5.6100 / 5.6400
  • Day Range
    Low 4.6705
    High 5.6100
  • 52 Week Range
    Low 3.6100
    High 37.0900
  • Volume
    995,447
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 5.64
TimeVolumeBMEA
09:32 ET240385.5501
09:34 ET73575.45
09:36 ET311595.42
09:38 ET74925.49
09:39 ET138585.51
09:41 ET343485.48
09:43 ET75735.4602
09:45 ET162265.325
09:48 ET425825.1699
09:50 ET528095.05
09:52 ET216535.08
09:54 ET218605.02
09:56 ET213425.09
09:57 ET127265.05
09:59 ET1022014.79
10:01 ET294284.78
10:03 ET456634.79
10:06 ET375454.73
10:08 ET193664.77
10:10 ET313154.93
10:12 ET151564.9499
10:14 ET134984.945
10:15 ET244274.9
10:17 ET78084.93
10:19 ET101614.8701
10:21 ET64184.8247
10:24 ET85654.86
10:26 ET63544.88
10:28 ET138744.845
10:30 ET137344.83
10:32 ET222624.82
10:33 ET56214.85
10:35 ET207554.805
10:37 ET166134.86
10:39 ET127994.86
10:42 ET15924.835
10:44 ET39554.815
10:46 ET108894.845
10:48 ET21404.85
10:50 ET88584.81
10:51 ET63894.8001
10:53 ET42004.82
10:55 ET15914.8168
10:57 ET134474.85
11:00 ET70674.81
11:02 ET36954.81
11:04 ET31004.825
11:06 ET100554.83
11:08 ET130894.9001
11:09 ET52394.9
11:11 ET81884.9199
11:13 ET55064.8955
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBMEA
Biomea Fusion Inc
202.7M
-1.4x
---
United StatesVTYX
Ventyx Biosciences Inc
203.0M
-0.8x
---
United StatesRANI
Rani Therapeutics Holdings Inc
203.2M
-3.2x
---
United StatesDSGN
Design Therapeutics Inc
209.6M
-3.5x
---
United StatesPRLD
Prelude Therapeutics Inc
214.2M
-2.1x
---
United StatesGLSI
Greenwich Lifesciences Inc
190.1M
-22.3x
---
As of 2024-06-17

Company Information

Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).

Contact Information

Headquarters
900 Middlefield Road, 4Th FloorREDWOOD CITY, CA, United States 94063
Phone
650-980-9099
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Thomas Butler
President, Co-Founder, Chief Operating Officer, Director
Rainer Erdtmann
Chief Financial Officer
Franco Valle
Chief Medical Officer
Juan Fras
Independent Director
Eric Aguiar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$202.7M
Revenue (TTM)
$0.00
Shares Outstanding
35.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.57
Book Value
$4.72
P/E Ratio
-1.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.